The Educational Potential Of Direct-To-Consumer Prescription Drug Advertising
- 1 July 2004
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 23 (4), 143-150
- https://doi.org/10.1377/hlthaff.23.4.143
Abstract
Food and Drug Administration (FDA) regulations for direct-to-consumer (DTC) prescription drug advertising allow broadcast advertisements with incomplete risk information if the ads refer consumers to physicians, pharmacists, and supplemental information sources. New research reveals several problems with both television advertisements and supplemental text materials that might compromise their ability to meet the FDA’s requirement for “fair balance” in the presentation of risks and benefits. In response, we make several recommendations to improve the educational quality of DTC advertising, which can be implemented through either voluntary agreements or revised FDA regulations.Keywords
This publication has 11 references indexed in Scilit:
- Direct-to-Consumer Advertising — Education or Emotion Promotion?New England Journal of Medicine, 2002
- Direct-To-Consumer Prescription Drug Advertising: Trends, Impact, And ImplicationsHealth Affairs, 2000
- Easy-to-Read Consumer Communications: A Missing Link in Medicaid Managed CareJournal of Health Politics, Policy and Law, 1999
- Direct-to-Consumer Prescription Drug Advertising Builds Bridges Between Patients and PhysiciansJAMA, 1999
- Rote learning after exposure to a direct-to-consumer television advertisement for a prescription drugClinical Therapeutics, 1998
- Regulation of prescription drug promotion: direct-to-consumer advertisingClinical Therapeutics, 1998
- Direct-to-consumer prescription drug advertising.American Journal of Health-System Pharmacy, 1997
- Direct-to-Consumer Prescription Drug AdvertisingMedical Care, 1997
- Inadequate Functional Health Literacy-ReplyPublished by American Medical Association (AMA) ,1996
- Consumer attitudes about advertisements for medicinal drugsSocial Science & Medicine, 1986